arrow
R

Roberta Malaguarnera

universita degli studi di enna kore
H指数:36
被引数:4,054

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of baseline LDL-C and Lp(a) levels on PCSK9-targeting therapy efficacy in subjects with familial hypercholesterolemia: real-world data from a tertiary lipid center.

基线LDL-C和Lp(a)水平对家族性高胆固醇血症患者PCSK9靶向治疗效果的影响:来自三级血脂中心的真实世界数据

2026-10-150
OAAI
Assessment of N/L ratio and subclinical atherosclerosis in FH subjects with or without LDLR mutation

Di Giacomo Barbagallo, F.; Bosco, G.; Di Marco, M.; Scilletta, S.; Miano, N.; Martedì, M.; Privitera, I.; Papa, M.C.; Piazza, C.; Valenza, F.; 等. 对有无LDLR突变家族性高胆固醇血症患者N/L比值和亚临床动脉粥样硬化的评估. J. Endocr. Soc. 2026, 10, bvag001. [Google Scholar] [CrossRef] [PubMed]

2026-03-017
PRE
Molecular advancements in targeting fibroblast activation protein (FAP) in cancer therapies

靶向癌疗法中针对成纤维细胞活化蛋白(FAP)的分子进展

2026-01-010
OA
Alternate actions of CDK4/6 inhibitors beyond cell cycle blockade: unexplored roles in therapy resistance

CDK4/6抑制剂的替代作用:超越细胞周期阻断的机制——对治疗抵抗中未探索角色的研究

2025-12-120
OAAI
Impairment of Regenerative and Metabolic Pathways in Intestinal Organoids From Patients With MASLD-Cirrhosis

MASLD肝硬化患者肠道类器官中再生和代谢通路的损害

2025-09-100
PRE
Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience

inclisiran对家族性高胆固醇血症患者血脂和血管机械特征的影响:来自单一血脂中心的真实世界研究结果

2025-05-260
PREAI
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
CELLS
IF5.2
2021-11-1213
OAAI